Transient leukemia in newborns with Down syndrome

Area of Science:

• Pediatric Oncology
• Hematology
• Genetics

Background:

• Children with Down syndrome (DS) have a significantly higher risk of leukemia.
• A unique form of leukemia, transient leukemia (TL), occurs in newborns with DS or trisomy 21 mosaicism.
• TL is characterized by a clonal proliferation of blast cells with megakaryocytic features.

Purpose of the Study:

• To summarize the clinical, biological, and cytogenetic features of transient leukemia (TL) in newborns with Down syndrome (DS).

Main Methods:

• Review of existing clinical data.
• Analysis of biological and genetic research findings.
• Summarization of cooperative group trials.

Main Results:

• TL presents with varying severity, from incidental findings to life-threatening conditions like hydrops fetalis.
• Approximately 13-33% of children with DS-associated TL develop subsequent acute megakaryoblastic leukemia.
• The true incidence of TL in DS newborns requires further determination.

Conclusions:

• Transient leukemia in Down syndrome newborns is a distinct entity with a high risk of spontaneous remission but also a significant risk of progression to fatal leukemia.
• Understanding the clinical, biological, and cytogenetic features is crucial for managing this condition.
• Ongoing research and clinical trials aim to better characterize and manage TL in DS.